MET and neoplasm: However, anti-angiogenic drugs may promote tumor progression and distant metastasis, which may be related to tumor hypoxia and the expression of vascular endothelial growth factor A, fibroblast growth factor, ephrin A1, and the activation of the proto-oncogene c-Met (71).